Top of the morning to you, and a fine one it is. Sunny skies are enveloping the Pharmalot corporate campus, where we are enjoying the chirping birds, barking dogs and cool breezes wafting through the windows. This lovely atmosphere calls for a delicious cup of stimulation as we prepare for yet another very busy day. You know that feeling, of course. Meetings, deadlines, projects and not enough time for everything. To help you along, here are some tidbits. Hang in there, though. The weekend is approaching. Catch you soon...
FDA To Inspect Aurobindo Facilities (Business Standard)
Pfizer's Tofacitinib Improves Colitis In Mid-Stage Study (Dow Jones)
Lawyer Wants China To Probe Pfizer Over Bribes (People's Daily)
FTC And DOJ Propose Rule Change On Patent Acquisitions (Bloomberg News)
Novartis Drug Shows Promise For Age-Related Eye Disease (Wall Street Journal)
Biogen And Regulus Strike Deal To Monitor Multiple Sclerosis (Xconomy)
FDA Warns Over Codeine Risk In Children (Reuters)
Icahn Wins One Seat On Forest Labs Board (Bloomberg News)
Impax Labs Hopes Parkinson's Drug Is A Game Changer (Investor's Daily)
EDITOR'S NOTE: Please check this post for updates during the day
sunshine & flowers pic thx to rkramer62 on flickr